All Outputs (5)

Epithelial Interleukin‐1 Receptor‐Like‐1 Activation Is Contingent on Interleukin‐33 Isoforms and Asthma‐Related Receptor Variation (2024)
Journal Article
Portelli, M., Ketelaar, M., Bates, S., Csomor, E., Shaw, D., Emsley, J., Brightling, C., Hall, I., Affleck, K., Edwards, M., Nawijn, M., Koppelman, G., Van Oosterhout, A., & Sayers, I. (2024). Epithelial Interleukin‐1 Receptor‐Like‐1 Activation Is Contingent on Interleukin‐33 Isoforms and Asthma‐Related Receptor Variation. Clinical and Experimental Allergy, https://doi.org/10.1111/cea.14562

Introduction: The interleukin-33/interleukin-1 receptor-like-1 (IL-33/IL1RL1) signalling pathway is implicated in asthma pathogenesis, with IL1RL1 nonsynonymous genetic polymorphisms associated with disease risk. We aimed to determine these variants'... Read More about Epithelial Interleukin‐1 Receptor‐Like‐1 Activation Is Contingent on Interleukin‐33 Isoforms and Asthma‐Related Receptor Variation.

Interleukin‐1 receptor‐associated kinase 4 (IRAK4) is a critical regulator of inflammatory signalling through toll‐like receptors 4 and 7/8 in murine and human lungs (2024)
Journal Article
Sayers, I., Thakker, D., Billington, C., Kreideweiss, S., Grundl, M. A., Bouyssou, T., Thamm, S., Kreuz, S., & Hall, I. P. (2024). Interleukin‐1 receptor‐associated kinase 4 (IRAK4) is a critical regulator of inflammatory signalling through toll‐like receptors 4 and 7/8 in murine and human lungs. British Journal of Pharmacology, 181(22), 4647-4657. https://doi.org/10.1111/bph.16509

Background and Purpose: Toll‐like receptors 4 (TLR4) and TLR7/TLR8 play an important role in mediating the inflammatory effects of bacterial and viral pathogens. Interleukin‐1 receptor‐associated kinase 4 (IRAK4) is an important regulator of signalli... Read More about Interleukin‐1 receptor‐associated kinase 4 (IRAK4) is a critical regulator of inflammatory signalling through toll‐like receptors 4 and 7/8 in murine and human lungs.

Transcriptomics using lung resection material to advance our understanding of COPD and idiopathic pulmonary fibrosis pathogenesis (2024)
Journal Article
Rakkar, K., Thakkar, D., Portelli, M. A., Hall, I., Schlüter, H., & Sayers, I. (2024). Transcriptomics using lung resection material to advance our understanding of COPD and idiopathic pulmonary fibrosis pathogenesis. ERJ Open Research, 10(4), https://doi.org/10.1183/23120541.00061-2024

IL-33 induced gene expression in activated Th2 effector cells is dependent on IL-1RL1 haplotype and asthma status (2024)
Journal Article
Saikumar Jayalatha, A. K., Ketelaar, M. E., Hesse, L., Badi, Y. E., Zounemat-Kermani, N., Sharon, B., Dijk, N. F., van den Berge, M., Guryev, V., Sayers, I., Vonk, J. E., Adcock, I. M., Koppelman, G. H., & Nawijn, M. C. (2024). IL-33 induced gene expression in activated Th2 effector cells is dependent on IL-1RL1 haplotype and asthma status. European Respiratory Journal, 63(6), Article 2400005. https://doi.org/10.1183/13993003.00005-2024

Mepolizumab Induced Changes in Nasal Methylome and Transcriptome to Predict Response in Asthma (2024)
Journal Article
Rakkar, K., Pang, Y. L., Rajasekar, P., Portelli, M. A., Hall, R. J., Clifford, R. L., Shaw, D., & Sayers, I. (2024). Mepolizumab Induced Changes in Nasal Methylome and Transcriptome to Predict Response in Asthma. American Journal of Respiratory and Critical Care Medicine, 209(10), 1268-1272. https://doi.org/10.1164/rccm.202308-1477le